Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARgamma) agonist with potent glucose-lowering properties

Weidner, C., Wowro, S. J., Freiwald, A., Kawamoto, K., Witzke, A., Kliem, M., et al. (2013). Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARgamma) agonist with potent glucose-lowering properties. Diabetologia, 56(8), 1802-1812. doi:10.1007/s00125-013-2920-2.

Item is

Dateien

einblenden: Dateien
ausblenden: Dateien
:
Weidner.pdf (Verlagsversion), 507KB
Name:
Weidner.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/pdf / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
© 2013 Springer, Part of Springer Science+Business Media
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Weidner, C.1, Autor           
Wowro, S. J.1, Autor           
Freiwald, A.1, Autor           
Kawamoto, K., Autor
Witzke, A.1, Autor           
Kliem, M.1, Autor           
Siems, K., Autor
Müller-Kuhrt, L., Autor
Schroeder, F. C., Autor
Sauer, S.1, Autor           
Affiliations:
1Nutrigenomics and Gene Regulation (Sascha Sauer), Independent Junior Research Groups (OWL), Max Planck Institute for Molecular Genetics, Max Planck Society, Ihnestr. 73, 14195 Berlin, Germany, ou_1479662              

Inhalt

einblenden:
ausblenden:
Schlagwörter: Animals Cells, Cultured Diabetes Mellitus, Type 2/drug therapy Humans Hypoglycemic Agents/*therapeutic use Insulin Resistance/physiology Male Mice Mice, Inbred C57BL PPAR gamma/*agonists Salicylates/*therapeutic use
 Zusammenfassung: AIMS/HYPOTHESIS: The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) is an important gene regulator in glucose and lipid metabolism. Unfortunately, PPARgamma-activating drugs of the thiazolidinedione class provoke adverse side effects. As recently shown, amorfrutin A1 is a natural glucose-lowering compound that selectively modulates PPARgamma. In this study we aimed to characterise, in vitro, a large spectrum of the amorfrutins and similar molecules, which we isolated from various plants. We further studied in vivo the glucose-lowering effects of the so far undescribed amorfrutin B, which featured the most striking PPARgamma-binding and pharmacological properties of this family of plant metabolites. METHODS: Amorfrutins were investigated in vitro by binding and cofactor recruitment assays and by transcriptional activation assays in primary human adipocytes and murine preosteoblasts, as well as in vivo using insulin-resistant high-fat-diet-fed C57BL/6 mice treated for 27 days with 100 mg kg(-1) day(-1) amorfrutin B. RESULTS: Amorfrutin B showed low nanomolar binding affinity to PPARgamma, and micromolar binding to the isotypes PPARalpha and PPARbeta/delta. Amorfrutin B selectively modulated PPARgamma activity at low nanomolar concentrations. In insulin-resistant mice, amorfrutin B considerably improved insulin sensitivity, glucose tolerance and blood lipid variables after several days of treatment. Amorfrutin B treatment did not induce weight gain and furthermore showed liver-protecting properties. Additionally, amorfrutins had no adverse effects on osteoblastogenesis and fluid retention. CONCLUSIONS/INTERPRETATION: The application of plant-derived amorfrutins or synthetic analogues thereof constitutes a promising approach to prevent or treat complex metabolic diseases such as insulin resistance or type 2 diabetes.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2013-05-182013-08
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: DOI: 10.1007/s00125-013-2920-2
ISSN: 1432-0428 (Electronic)0012-186X (Print)
URI: http://www.ncbi.nlm.nih.gov/pubmed/23680913
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Diabetologia
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: Heidelberg : Springer-Verlag Heidelberg
Seiten: - Band / Heft: 56 (8) Artikelnummer: - Start- / Endseite: 1802 - 1812 Identifikator: ISSN: 0012-186X
CoNE: https://pure.mpg.de/cone/journals/resource/954925394387